{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,27]],"date-time":"2026-02-27T04:20:09Z","timestamp":1772166009153,"version":"3.50.1"},"reference-count":30,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2022,5,3]],"date-time":"2022-05-03T00:00:00Z","timestamp":1651536000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2022,5,3]],"date-time":"2022-05-03T00:00:00Z","timestamp":1651536000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"name":"HDR-UK"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Med Inform Decis Mak"],"published-print":{"date-parts":[[2022,12]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Venous thromboembolism (VTE) causes significant mortality and morbidity in hospitalised patients. Risk factors for VTE are well known and there are validated risk assessment tools to support the use of prophylactic therapies. In England, reporting the percentage of patients with a completed VTE risk assessment is mandated, but this does not include whether that risk assessment resulted in appropriate prescribing. Full guideline compliance, defined as an assessment which led to an appropriate action\u2014here prescribing prophylactic low molecular weight heparin where indicated, is rarely reported. Education, audit and feedback enhance guideline compliance but electronic prescribing systems (EPS) can mandate guideline-compliant actions. We hypothesised that a systems-based EPS intervention (prescribing rules which mandate approval or rejection of a proposed prescription of prophylactic low molecular weight heparin based on the mandated VTE assessment) would increase full VTE guideline compliance more than interventions which focused on targeting individual prescribers.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>All admitted patients within University Hospitals Birmingham NHS Foundation Trust were included for analysis between 2011 and 2020. The proportion of patients who received a fully compliant risk assessment and action was assessed over time. Interventions included teaching sessions and face-to-face feedback based on measured performance (an approach targeting individual prescribers) and mandatory risk assessment and prescribing rules into an EPS (a systems approach).<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>\n                      Data from all 235,005 admissions and all 5503 prescribers were included in the analysis. Risk assessments were completed in\u2009&gt;\u200990\u201395% of all patients at all times, but full guideline compliance was lower (70% at the start of this study). Face-to-face feedback improved full VTE guideline compliance from 70 to 77% (\n                      <jats:italic>p<\/jats:italic>\n                      \u2009\u2264\u20090.001). Changes to the EPS to mandate assessment with prescribing rules increased full VTE compliance to 95% (\n                      <jats:italic>p<\/jats:italic>\n                      \u2009\u2264\u20090.001). Further amendments to the EPS system to reduce erroneous VTE assessments slightly reduced full compliance to 92% (\n                      <jats:italic>p<\/jats:italic>\n                      \u2009&lt;\u20090.001), but this was then maintained including during changes to the low molecular weight heparin used for VTE prophylaxis.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Discussion<\/jats:title>\n                    <jats:p>An EPS-systems approach was more effective in improving sustained guideline-compliant VTE prevention over time. Non-compliance remained at 8\u20135% despite this mandated system. Further research is needed to assess the potential reasons for this.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1186\/s12911-022-01865-y","type":"journal-article","created":{"date-parts":[[2022,5,3]],"date-time":"2022-05-03T09:03:48Z","timestamp":1651568628000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":5,"title":["Electronic prescribing systems as tools to improve patient care: a learning health systems approach to increase guideline concordant prescribing for venous thromboembolism prevention"],"prefix":"10.1186","volume":"22","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-1026-4125","authenticated-orcid":false,"given":"S.","family":"Gallier","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"A.","family":"Topham","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"P.","family":"Nightingale","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M.","family":"Garrick","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"I.","family":"Woolhouse","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M. A.","family":"Berry","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"T.","family":"Pankhurst","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3454-5482","authenticated-orcid":false,"given":"E.","family":"Sapey","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"S.","family":"Ball","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2022,5,3]]},"reference":[{"key":"1865_CR1","unstructured":"Arya A, Hunt B. Venous thromboembolism prevention a guide to deliverying the CQUIN goal. 2010;DOA 4th Nov 2019."},{"key":"1865_CR2","doi-asserted-by":"crossref","unstructured":"Kahn SR, Morrison DR, Diend\u00e9r\u00e9 G, Pich\u00e9 A, Filion KB, Klil\u2010Drori AJ, et al. Interventions for implementation of thromboprophylaxis in hospitalized patients at risk for venous thromboembolism. Cochrane Database Syst Rev. 2018(4).","DOI":"10.1002\/14651858.CD008201.pub3"},{"issue":"2","key":"1865_CR3","doi-asserted-by":"publisher","first-page":"157","DOI":"10.1111\/imj.13679","volume":"48","author":"JM Stubbs","year":"2018","unstructured":"Stubbs JM, Assareh H, Curnow J, Hitos K, Achat HM. Incidence of in-hospital and post-discharge diagnosed hospital-associated venous thromboembolism using linked administrative data. Intern Med J. 2018;48(2):157\u201365.","journal-title":"Intern Med J"},{"key":"1865_CR4","doi-asserted-by":"crossref","unstructured":"Anderson FA, Spencer FA. Risk factors for venous thromboembolism. Circulation. 2003;107(23_suppl_1):I-9-I-16.","DOI":"10.1161\/01.CIR.0000078469.07362.E6"},{"key":"1865_CR5","unstructured":"National Institute for Health and Care Excellence. Venous thromboembolism in over 16s: reducing the risk of hospital-acquired deep vein thrombosis or pulmonary embolism. 2019;DOA 2.12.2019."},{"issue":"10","key":"1865_CR6","doi-asserted-by":"publisher","first-page":"1577","DOI":"10.1001\/jamainternmed.2014.3384","volume":"174","author":"SA Flanders","year":"2014","unstructured":"Flanders SA, Greene MT, Grant P, Kaatz S, Paje D, Lee B, et al. Hospital performance for pharmacologic venous thromboembolism prophylaxis and rate of venous thromboembolism\u202f: a cohort study. JAMA Intern Med. 2014;174(10):1577\u201384.","journal-title":"JAMA Intern Med"},{"issue":"6","key":"1865_CR7","doi-asserted-by":"publisher","first-page":"489","DOI":"10.1007\/s11606-010-1296-y","volume":"25","author":"MB Rothberg","year":"2010","unstructured":"Rothberg MB, Lahti M, Pekow PS, Lindenauer PK. Venous thromboembolism prophylaxis among medical patients at US hospitals. J Gen Intern Med. 2010;25(6):489\u201394.","journal-title":"J Gen Intern Med"},{"key":"1865_CR8","unstructured":"Kings Thrombosis Centre. Venous Thromboembolism Prevention A Guide for Delivering the CQUIN Goal. http:\/\/www.kingsthrombosiscentreorguk\/kings\/Delivering%20the%20CQUIN%20Goal_2ndEdition_LRpdf. 2010;DOA 26th Nov 2020."},{"key":"1865_CR9","unstructured":"NHS Commissioning Board. Commissioning for Quality and Innovation (CQUIN) 2013\/2014 Guidance. https:\/\/www.englandnhsuk\/wp-content\/uploads\/2012\/12\/cquin-guidancepdf. 2012;DOA 26 Nov 2020."},{"key":"1865_CR10","unstructured":"National Institute for Health and Care Excellence. Venous thromboembolism in over 16s: reducing the risk of hospital-acquired deep vein thrombosis or pulmonary embolism NICE guideline [NG89]. https:\/\/www.niceorguk\/guidance\/ng89. 2019;DOA 26 Nov 2020."},{"key":"1865_CR11","unstructured":"NHS England and NHS Improvement. Venous thromboembolism risk assessment data collection Quarter 1 2019\/20 (April to June 2019). https:\/\/www.improvementnhsuk\/documents\/5938\/VTE-Commentary-Q1-2019-20pdf. 2020;DOA 26 Nov 2020."},{"issue":"6","key":"1865_CR12","doi-asserted-by":"publisher","first-page":"624","DOI":"10.1111\/j.1365-2125.2009.03425.x","volume":"67","author":"GP Velo","year":"2009","unstructured":"Velo GP, Minuz P. Medication errors: prescribing faults and prescription errors. Br J Clin Pharmacol. 2009;67(6):624\u20138.","journal-title":"Br J Clin Pharmacol"},{"issue":"9315","key":"1865_CR13","doi-asserted-by":"publisher","first-page":"1373","DOI":"10.1016\/S0140-6736(02)08350-2","volume":"359","author":"B Dean","year":"2002","unstructured":"Dean B, Schachter M, Vincent C, Barber N. Causes of prescribing errors in hospital inpatients: a prospective study. The Lancet. 2002;359(9315):1373\u20138.","journal-title":"The Lancet"},{"issue":"4","key":"1865_CR14","doi-asserted-by":"publisher","first-page":"1276","DOI":"10.1378\/chest.13-0267","volume":"144","author":"LN Roberts","year":"2013","unstructured":"Roberts LN, Porter G, Barker RD, Yorke R, Bonner L, Patel RK, et al. Comprehensive VTE prevention program incorporating mandatory risk assessment reduces the incidence of hospital-associated thrombosis. Chest. 2013;144(4):1276\u201381.","journal-title":"Chest"},{"issue":"2","key":"1865_CR15","doi-asserted-by":"publisher","first-page":"119","DOI":"10.1016\/j.amjopharm.2008.06.001","volume":"6","author":"L Yourman","year":"2008","unstructured":"Yourman L, Concato J, Agostini JV. Use of computer decision support interventions to improve medication prescribing in older adults: a systematic review. Am J Geriatr Pharmacother. 2008;6(2):119\u201329.","journal-title":"Am J Geriatr Pharmacother"},{"issue":"5","key":"1865_CR16","doi-asserted-by":"publisher","first-page":"381","DOI":"10.1136\/bmjqs.2010.042689","volume":"20","author":"BJ Lesselroth","year":"2011","unstructured":"Lesselroth BJ, Yang J, McConnachie J, Brenk T, Winterbottom L. Addressing the sociotechnical drivers of quality improvement: a case study of post-operative DVT prophylaxis computerised decision support. BMJ Qual Saf. 2011;20(5):381.","journal-title":"BMJ Qual Saf"},{"issue":"1","key":"1865_CR17","doi-asserted-by":"publisher","first-page":"120","DOI":"10.1186\/s12875-018-0808-4","volume":"19","author":"WY Lim","year":"2018","unstructured":"Lim WY, Hss AS, Ng LM, John Jasudass SR, Sararaks S, Vengadasalam P, et al. The impact of a prescription review and prescriber feedback system on prescribing practices in primary care clinics: a cluster randomised trial. BMC Fam Pract. 2018;19(1):120.","journal-title":"BMC Fam Pract"},{"issue":"8","key":"1865_CR18","doi-asserted-by":"publisher","first-page":"e403","DOI":"10.1016\/S2589-7500(19)30158-X","volume":"1","author":"SP Slight","year":"2019","unstructured":"Slight SP, Tolley CL, Bates DW, Fraser R, Bigirumurame T, Kasim A, et al. Medication errors and adverse drug events in a UK hospital during the optimisation of electronic prescriptions: a prospective observational study. Lancet Digital Health. 2019;1(8):e403\u201312.","journal-title":"Lancet Digital Health"},{"issue":"7237","key":"1865_CR19","doi-asserted-by":"publisher","first-page":"750","DOI":"10.1136\/bmj.320.7237.750","volume":"320","author":"PG Nightingale","year":"2000","unstructured":"Nightingale PG, Adu D, Richards NT, Peters M. Implementation of rules based computerised bedside prescribing and administration: intervention study. BMJ (Clin Res Ed). 2000;320(7237):750\u20133.","journal-title":"BMJ (Clin Res Ed)"},{"issue":"6","key":"1865_CR20","doi-asserted-by":"publisher","first-page":"508","DOI":"10.1002\/jppr.1562","volume":"49","author":"GC Soo","year":"2019","unstructured":"Soo GC, Wong Doo NC, Burrows J, Ritchie A, Zhang J, Burke R. Improving the adoption of an electronic clinical decision support tool and evaluating its effect on venous thromboembolism prophylaxis prescribing at a Sydney tertiary teaching hospital. J Pharm Pract Res. 2019;49(6):508\u201316.","journal-title":"J Pharm Pract Res"},{"key":"1865_CR21","unstructured":"(US); IoM, Grossmann C, Powers B, McGinnis JM e. Digital Infrastructure for the Learning Health System: The Foundation for Continuous Improvement in Health and Health Care: Workshop Series Summary. Washington (DC): National Academies Press (US); 2011 Institute of Medicine Roundtable on Value & Science-Driven Health Care 2012. https:\/\/www.ncbi.nlm.nih.gov\/books\/NBK83568\/."},{"issue":"4","key":"1865_CR22","doi-asserted-by":"publisher","first-page":"250","DOI":"10.1136\/bmjqs-2014-003623","volume":"24","author":"S Hignett","year":"2015","unstructured":"Hignett S, Jones EL, Miller D, Wolf L, Modi C, Shahzad MW, et al. Human factors and ergonomics and quality improvement science: integrating approaches for safety in healthcare. BMJ Qual Saf. 2015;24(4):250.","journal-title":"BMJ Qual Saf"},{"key":"1865_CR23","doi-asserted-by":"publisher","first-page":"69","DOI":"10.1177\/0027432111414432","volume":"98","author":"K Saville","year":"2001","unstructured":"Saville K. Strategies for using repetation as a powerful teaching tool. Music Educ J. 2001;98:69\u201375.","journal-title":"Music Educ J"},{"issue":"2","key":"1865_CR24","doi-asserted-by":"publisher","first-page":"186","DOI":"10.2307\/1419320","volume":"70","author":"I Rock","year":"1957","unstructured":"Rock I. The role of repetition in associative learning. Am J Psychol. 1957;70(2):186\u201393.","journal-title":"Am J Psychol"},{"issue":"4","key":"1865_CR25","doi-asserted-by":"publisher","first-page":"525","DOI":"10.1016\/j.apergo.2006.04.011","volume":"37","author":"P Carayon","year":"2006","unstructured":"Carayon P. Human factors of complex sociotechnical systems. Appl Ergon. 2006;37(4):525\u201335.","journal-title":"Appl Ergon"},{"key":"1865_CR26","doi-asserted-by":"publisher","first-page":"129","DOI":"10.1186\/s12875-015-0344-4","volume":"16","author":"K Moffat","year":"2015","unstructured":"Moffat K, Mercer SW. Challenges of managing people with multimorbidity in today\u2019s healthcare systems. BMC Family Practice. 2015;16:129.","journal-title":"BMC Family Practice."},{"issue":"2","key":"1865_CR27","doi-asserted-by":"publisher","first-page":"e000903","DOI":"10.1136\/bmjoq-2019-000903","volume":"9","author":"H Preston","year":"2020","unstructured":"Preston H, Swan I, Davies L, Dummer S, Veiraiah A, Beh YY, et al. Improving VTE risk assessment and prophylaxis prescribing rate in medical patients: integrating risk assessment tool into the workflow. BMJ Open Quality. 2020;9(2):e000903.","journal-title":"BMJ Open Quality"},{"issue":"3","key":"1865_CR28","doi-asserted-by":"publisher","first-page":"e000680","DOI":"10.1136\/bmjoq-2019-000680","volume":"9","author":"M Nana","year":"2020","unstructured":"Nana M, Shute C, Williams R, Kokwaro F, Riddick K, Lane H. Multidisciplinary, patient-centred approach to improving compliance with venous thromboembolism (VTE) prophylaxis in a district general hospital. BMJ Open Quality. 2020;9(3):e000680.","journal-title":"BMJ Open Quality"},{"issue":"2","key":"1865_CR29","doi-asserted-by":"publisher","first-page":"e000653","DOI":"10.1136\/openhrt-2017-000653","volume":"4","author":"HR Rowswell","year":"2017","unstructured":"Rowswell HR, Nokes TJC. Significant reduction in hospital-acquired thrombosis: impact of national risk assessment and real-time feedback. Open Heart. 2017;4(2):e000653.","journal-title":"Open Heart"},{"key":"1865_CR30","doi-asserted-by":"crossref","unstructured":"Akinbobuyi O, shalders l, Nokes T. Ensuring timely thromboprophylaxis on a Medical Assessment Unit. BMJ Quality Improvem Rep. 2016;5(1):u212414.w4934.","DOI":"10.1136\/bmjquality.u212414.w4934"}],"container-title":["BMC Medical Informatics and Decision Making"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12911-022-01865-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12911-022-01865-y\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12911-022-01865-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,5,3]],"date-time":"2022-05-03T09:06:24Z","timestamp":1651568784000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcmedinformdecismak.biomedcentral.com\/articles\/10.1186\/s12911-022-01865-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,5,3]]},"references-count":30,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2022,12]]}},"alternative-id":["1865"],"URL":"https:\/\/doi.org\/10.1186\/s12911-022-01865-y","relation":{"has-preprint":[{"id-type":"doi","id":"10.1101\/2021.01.11.21249606","asserted-by":"object"}]},"ISSN":["1472-6947"],"issn-type":[{"value":"1472-6947","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,5,3]]},"assertion":[{"value":"1 February 2021","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 April 2022","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"3 May 2022","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors confirm that all methods were carried out in accordance with relevant guidelines and regulations. This research used anonymised, routinely collected health data from the electronic health records of University Hospitals Birmingham NHS Foundation Trust. All research activities, including the use of unconsented health data, were conducted with appropriate UK Health Research Authority and Research Ethical Committee (East Midlands\u2014Derby Research ethics committee, reference 20\/EM\/0158) and HRA Confidentiality Advisory Group approvals (20\/CAG\/0084).","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"N\/A.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"P Nightingale, T Pankhurst, I Woolhouse, MA Berry, M Garrick report no conflicts of interest. S Gallier, A Topham and S Ball reports funding support from the HDRUK. E Sapey reports funding support from HDRUK, MRC, Wellcome Trust, NIHR, Alpha 1 Foundation, EPSRC and British Lung Foundation.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"121"}}